Estimated antiretroviral therapy coverage among people living with HIV in Trinidad and Tobago
Trinidad and Tobago: Estimated antiretroviral therapy coverage among people living with HIV was 66.0% in 2025. ◆ Volatile
Estimated antiretroviral therapy coverage among people living with HIV in Trinidad and Tobago, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, estimated antiretroviral therapy coverage among people living with hiv in Trinidad and Tobago stood at 66.0%.
Compared with earlier readings it is up 4.8% on the previous year and up 11.9% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in Trinidad and Tobago peaked at 69.0% in 2019 and was at its lowest, 0.0%, in 2000.
Trinidad and Tobago ranks 95th of 143 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among people living with HIV in Trinidad and Tobago, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 1.0% | — |
| 2002 | 3.0% | +200.0% |
| 2003 | 6.0% | +100.0% |
| 2004 | 9.0% | +50.0% |
| 2005 | 13.0% | +44.4% |
| 2006 | 16.0% | +23.1% |
| 2007 | 20.0% | +25.0% |
| 2008 | 24.0% | +20.0% |
| 2009 | 30.0% | +25.0% |
| 2010 | 39.0% | +30.0% |
| 2011 | 42.0% | +7.7% |
| 2012 | 48.0% | +14.3% |
| 2013 | 53.0% | +10.4% |
| 2014 | 56.0% | +5.7% |
| 2015 | 59.0% | +5.4% |
| 2016 | 59.0% | +0.0% |
| 2017 | 60.0% | +1.7% |
| 2018 | 64.0% | +6.7% |
| 2019 | 69.0% | +7.8% |
| 2020 | 64.0% | -7.2% |
| 2021 | 64.0% | +0.0% |
| 2022 | 63.0% | -1.6% |
| 2023 | 64.0% | +1.6% |
| 2024 | 63.0% | -1.6% |
| 2025 | 66.0% | +4.8% |
Trinidad and Tobago compared with similar countries
- Trinidad and Tobago's 66.0% is below the median for high income countries, which is 81.5%, 81% of the median. (42 countries reporting)
- Trinidad and Tobago's 66.0% is below the median for Latin America & Caribbean, which is 69.0%, 96% of the median. (27 countries reporting)
Biggest year-on-year movements
Years where Estimated antiretroviral therapy coverage among people living with HIV in Trinidad and Tobago changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2002 | +200.0% | 1.0% | 3.0% |
| 2003 | +100.0% | 3.0% | 6.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 12.2% | 0.0% | 30.0% | 10 |
| 2010s | 54.9% | 39.0% | 69.0% | 10 |
| 2020s | 64.0% | 63.0% | 66.0% | 6 |
Countries ranked near Trinidad and Tobago
- 92 Barbados 67.0% compare
- 92 Mexico 67.0% compare
- 92 Panama 67.0% compare
- 95 Timor-Leste 66.0% compare
- 95 Niger 66.0% compare
- 98 Dominican Republic 65.0% compare
- 98 Venezuela, Bolivarian Republic of 65.0% compare
- 98 Syrian Arab Republic 65.0% compare
More health data for Trinidad and Tobago
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1463 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,638 deaths per 1,000 people (2090)
- Number of infants who die before age 1 24 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.35 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0263 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.36 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in Trinidad and Tobago?
- Estimated antiretroviral therapy coverage among people living with hiv in Trinidad and Tobago was 66.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in Trinidad and Tobago?
- The highest recorded value was 69.0% in 2019.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in Trinidad and Tobago?
- The lowest recorded value was 0.0% in 2000.
- How does Trinidad and Tobago rank for estimated antiretroviral therapy coverage among people living with hiv?
- Trinidad and Tobago ranks 95th out of 143 countries with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in Trinidad and Tobago?
- Over the last ten years it is up 11.9%. The long-run trend across the full record is volatile.
- Where does this Trinidad and Tobago data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).